company background image
4528 logo

Ono Pharmaceutical TSE:4528 Stock Report

Last Price

JP¥2.13k

Market Cap

JP¥1.0t

7D

-4.6%

1Y

-20.5%

Updated

13 Jun, 2024

Data

Company Financials +

Ono Pharmaceutical Co., Ltd.

TSE:4528 Stock Report

Market Cap: JP¥1.0t

Ono Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ono Pharmaceutical
Historical stock prices
Current Share PriceJP¥2,125.50
52 Week HighJP¥2,966.50
52 Week LowJP¥2,153.50
Beta0.17
1 Month Change-8.68%
3 Month Change-15.34%
1 Year Change-20.54%
3 Year Change-14.76%
5 Year Change8.31%
Change since IPO72.80%

Recent News & Updates

Recent updates

Ono Pharmaceutical (TSE:4528) Has Announced A Dividend Of ¥40.00

Mar 04
Ono Pharmaceutical (TSE:4528) Has Announced A Dividend Of ¥40.00

Is There An Opportunity With Ono Pharmaceutical Co., Ltd.'s (TSE:4528) 42% Undervaluation?

Feb 27
Is There An Opportunity With Ono Pharmaceutical Co., Ltd.'s (TSE:4528) 42% Undervaluation?

Shareholder Returns

4528JP PharmaceuticalsJP Market
7D-4.6%-0.7%0.3%
1Y-20.5%-0.7%17.5%

Return vs Industry: 4528 underperformed the JP Pharmaceuticals industry which returned -0.7% over the past year.

Return vs Market: 4528 underperformed the JP Market which returned 17.5% over the past year.

Price Volatility

Is 4528's price volatile compared to industry and market?
4528 volatility
4528 Average Weekly Movement2.9%
Pharmaceuticals Industry Average Movement3.7%
Market Average Movement3.9%
10% most volatile stocks in JP Market7.5%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 4528 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4528's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
17173,761Gyo Sagarawww.ono-pharma.com

Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia. The company also provides Glactiv tablets for type 2 diabetes; Forxiga tablets for diabetes; Onoact Intravenous Infusion for tachyarrhythmia; Opalmon tablets to treat peripheral circulatory disorder; Coralan for chronic heart failure; Orencia injections for rheumatoid arthritis; Rivastach patches for Alzheimer’s disease; Ongentys tablets for Parkinson’s disease; Parsabiv, an intravenous infusion for dialysis patients; Staybla tablets for overactive bladder; Onon capsules and Dry Syrups for bronchial asthma and allergic rhinitis; and JOYCLU intra-articular injection for the improvement of joint function, as well as Recalbon tablets for osteoporosis.

Ono Pharmaceutical Co., Ltd. Fundamentals Summary

How do Ono Pharmaceutical's earnings and revenue compare to its market cap?
4528 fundamental statistics
Market capJP¥1.01t
Earnings (TTM)JP¥127.98b
Revenue (TTM)JP¥502.67b

7.8x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4528 income statement (TTM)
RevenueJP¥502.67b
Cost of RevenueJP¥127.13b
Gross ProfitJP¥375.55b
Other ExpensesJP¥247.57b
EarningsJP¥127.98b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)272.50
Gross Margin74.71%
Net Profit Margin25.46%
Debt/Equity Ratio0%

How did 4528 perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

30%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.